These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 26990027

  • 1. Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics.
    Kaczor AA, Silva AG, Loza MI, Kolb P, Castro M, Poso A.
    ChemMedChem; 2016 Apr 05; 11(7):718-29. PubMed ID: 26990027
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aromatic linker variations in novel dopamine D2 and D3 receptor ligands.
    Di Biase C, Leitzbach L, Frank A, Zivkovic A, Stark H.
    Arch Pharm (Weinheim); 2024 Aug 05; 357(8):e2400071. PubMed ID: 38736025
    [Abstract] [Full Text] [Related]

  • 4. 1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation.
    Möller D, Salama I, Kling RC, Hübner H, Gmeiner P.
    Bioorg Med Chem; 2015 Sep 15; 23(18):6195-209. PubMed ID: 26299826
    [Abstract] [Full Text] [Related]

  • 5. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
    Chłoń-Rzepa G, Zagórska A, Bucki A, Kołaczkowski M, Pawłowski M, Satała G, Bojarski AJ, Partyka A, Wesołowska A, Pękala E, Słoczyńska K.
    Arch Pharm (Weinheim); 2015 Apr 15; 348(4):242-53. PubMed ID: 25773907
    [Abstract] [Full Text] [Related]

  • 6. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P, Carlson EE, Cao J, Bennett CJ, McElveen E, Taylor M, Luedtke RR, Newman AH.
    J Med Chem; 2005 Feb 10; 48(3):839-48. PubMed ID: 15689168
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening.
    Zięba A, Bartuzi D, Stępnicki P, Matosiuk D, Wróbel TM, Laitinen T, Castro M, Kaczor AA.
    ChemMedChem; 2024 Jul 15; 19(14):e202400080. PubMed ID: 38619283
    [Abstract] [Full Text] [Related]

  • 10. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 15; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor.
    Hjerde E, Dahl SG, Sylte I.
    Eur J Med Chem; 2005 Feb 15; 40(2):185-94. PubMed ID: 15694653
    [Abstract] [Full Text] [Related]

  • 13. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH, Mokrosz MJ, Charakchieva-Minol S, Duszyńska B, Kozioł A, Wesołowska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2003 Feb 15; 55(4):543-52. PubMed ID: 14581712
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic.
    Kaczor AA, Targowska-Duda KM, Budzyńska B, Biała G, Silva AG, Castro M.
    Neurochem Int; 2016 Jun 15; 96():84-99. PubMed ID: 26964765
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proof of concept study for designed multiple ligands targeting the dopamine D2, serotonin 5-HT2A, and muscarinic M1 acetylcholine receptors.
    Szabo M, Lim HD, Herenbrink CK, Christopoulos A, Lane JR, Capuano B.
    J Med Chem; 2015 Feb 12; 58(3):1550-5. PubMed ID: 25590655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.